Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Severe Acute Respiratory Syndrome (SARS) - Overview
Severe Acute Respiratory Syndrome (SARS) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Severe Acute Respiratory Syndrome (SARS) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Severe Acute Respiratory Syndrome (SARS) - Companies Involved in Therapeutics Development
Abhelix LLC
Atriva Therapeutics GmbH
Autoimmune Technologies LLC
Biotron Ltd
CEL-SCI Corp
Fab’entech SA
GeneCure LLC
Gilead Sciences Inc
Novavax Inc
Oncovir Inc
Phelix Therapeutics LLC
Sagimet Biosciences
Severe Acute Respiratory Syndrome (SARS) - Drug Profiles
ATR-006 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CEL-1000 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CSW-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs to Inhibit Cathepsin L for Coroviridae Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FDX-000 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LB-2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ML-188 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibodies for Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody for SARS Virus Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Poly-ICLC - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
remdesivir - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SARS (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
severe acute respiratory syndrome vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit Corovirus E Protein for Severe Acute Respiratory Syndrome - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SSYA-10001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TVB-3567 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccine for Severe Acute Respiratory Syndrome - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Severe Acute Respiratory Syndrome (SARS) - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Severe Acute Respiratory Syndrome (SARS), H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019

 

List of Tables


Number of Products under Development for Severe Acute Respiratory Syndrome (SARS), H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by Abhelix LLC, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by Atriva Therapeutics GmbH, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by Autoimmune Technologies LLC, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by Biotron Ltd, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by CEL-SCI Corp, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by Fab’entech SA, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by GeneCure LLC, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by Gilead Sciences Inc, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by Novavax Inc, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by Oncovir Inc, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by Phelix Therapeutics LLC, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Pipeline by Sagimet Biosciences, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Dormant Projects, H2 2019
Severe Acute Respiratory Syndrome (SARS) - Dormant Projects, H2 2019 (Contd..1), H2 2019